The tumour suppressor phosphatase and tensin homolog (PTEN) is mutated in approximately 40% of melanomas leading to its loss of function and the subsequent upregulation of the PI3K/AKT pathway and an increase in metastasis [43]. Here, PTEN is linked to melanoma.